Literature DB >> 4841278

The immune competence of patients with inflammatory bowel disease.

P M Bolton, S L James, R G Newcombe, R H Whitehead, L E Hughes.   

Abstract

Previous investigations of immune function in patients with Crohn's disease have yielded conflicting results. A comprehensive study of immune competence-peripheral lymphocyte count, serum immunoglobulin levels (IgG, IgA and IgM), lymphocyte response to PHA, Mantoux test, and DNCB response-has been performed in a large number of patients with inflammatory bowel disease. A total of 52 patients with Crohn's disease, 20 patients with ulcerative colitis, and 46 control patients with benign gastrointestinal disease were investigated. The patient groups were subdivided into ;well' and ;ill' in view of the differing clinical states of patients with inflammatory bowel disease. Some of the Crohn's and colitis patients were receiving steroid therapy. The peripheral blood lymphocyte count and lymphocyte response to PHA were similar in all patient groups. Serum IgA levels were elevated in Crohn's disease but fell significantly in ;ill' Crohn's patients following excisional surgery. Serum IgM levels rose significantly in ;ill' Crohn's patients after surgery. Steroid therapy was associated with diminution of both Mantoux and DNCB responses in the ;ill' Crohn's patients. There was no evidence of impairment of immune competence in either Crohn's disease or ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4841278      PMCID: PMC1412882          DOI: 10.1136/gut.15.3.213

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOOD.

Authors:  A S COULSON; D G CHALMERS
Journal:  Lancet       Date:  1964-02-29       Impact factor: 79.321

2.  The relation between regional ileitis and sarcoidosis.

Authors:  D N PHEAR
Journal:  Lancet       Date:  1958-12-13       Impact factor: 79.321

3.  The ability of ACTH and cortisone to alter delayed type bacterial hypersensitivity.

Authors:  J B LONG; C B FAVOUR
Journal:  Bull Johns Hopkins Hosp       Date:  1950-09

4.  Tuberculin sensitivity in Crohn's disease. A controlled study.

Authors:  J Fletcher; J M Hinton
Journal:  Lancet       Date:  1967-10-07       Impact factor: 79.321

5.  Short-term lymphocyte cultures in regional enteritis.

Authors:  S M Brown; R N Taub; D H Present; H D Janowitz
Journal:  Lancet       Date:  1970-05-23       Impact factor: 79.321

6.  Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease.

Authors:  P Asquith; S C Kraft; R M Rothberg
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

7.  Lymphocyte transformation and delayed hypersensitivity in Crohn's disease.

Authors:  C Röpke
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

8.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

9.  A study of the immunologic aspects of chronic ulcerative colitis and transmural colitis.

Authors:  S D Deodhar; W M Michener; R G Farmer
Journal:  Am J Clin Pathol       Date:  1969-05       Impact factor: 2.493

10.  Delayed hypersensitivity and lymphocyte transformation in Crohn's disease and proctocolitis.

Authors:  J G Walker; M F Greaves
Journal:  Gut       Date:  1969-05       Impact factor: 23.059

View more
  26 in total

1.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

2.  [Immune defect syndrome in Crohn's disease (author's transl)].

Authors:  K Kleesiek; E Masseck; Z Pusztai-Markos; W Spölgen; T Raguse; H P Bräcker
Journal:  Klin Wochenschr       Date:  1978-12-15

3.  Immune status in Crohn's disease. 2. Originally unimpaired primary cell mediated immunity in vitro.

Authors:  I O Auer; C Buschmann; E Ziemer
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

4.  Immunological studies in patients with Crohn's disease.

Authors:  B R MacPherson; R J Albertini; W L Beeken
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

5.  Impaired anamnestic cellular immune response in patients with Crohn's disease.

Authors:  S G Meuwissen; P T Schellekens; L Huismans; G N Tytgat
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

6.  Studies on the subpopulation and function of peripheral lymphocytes, and lymphocyte reactivity to colonic mucosal antigen and bacterial antigen in patients with ulcerative colitis and Crohn's disease.

Authors:  K Kobayashi; A Kitano; S Mizuno; K Yamaguchi; Y Mizoguchi
Journal:  Gastroenterol Jpn       Date:  1978

Review 7.  Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.

Authors:  Eric Gracey; Lars Vereecke; Dermot McGovern; Mareike Fröhling; Georg Schett; Silvio Danese; Martine De Vos; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

8.  In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD.

Authors:  J J Lyanga; P Davis; A B Thomson
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

9.  Double-blind trial of the use of transfer factor in the treatment of Crohn's disease.

Authors:  F R Vicary; J D Chambers; P Dhillon
Journal:  Gut       Date:  1979-05       Impact factor: 23.059

10.  Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.

Authors:  J Lyanga; P Davis; A B Thomson
Journal:  West J Med       Date:  1988-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.